The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
RETRACTED: Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study
Open accessAbstract
Objective To determine whether GnRHa administration before and during combination chemotherapy for breast cancer could preserve posttreatment ovarian function in young women or not. Design Prospective randomized controlled study. Setting Department of Obstetrics and Gynecology, Mansura University Hospital, Mansura, Egypt. Patient(s) Eighty patients with unilateral adenocarcinoma of the breast and with no metastasis who had undergone modified radical mastectomy or breast-conserving surgery plus full axillary lymph node dissection were included in the study. Patients were assigned randomly to receive combined GnRHa and chemotherapy or chemotherapy alone. One woman in each group dropped out. Main outcome measure(s) Return of spontaneous menstruation and ovulation. Hormonal changes (FSH, LH, E(2), P) during and after the course of treatment. Result(s) In the study group, 89.6% resumed menses and 69.2% resumed spontaneous ovulation within 3-8 months of termination of the GnRHa/chemotherapy cotreatment; 11.4% experienced hypergonadotrophic amenorrhoea and ovarian failure 8 months after treatment. In the control group (chemotherapy without GnRHa), 33.3% resumed menses and 25.6% resumed normal ovarian activity. The median FSH and LH concentrations, 6 months after completion of the GnRHa/chemotherapy cotreatment group, were significantly less than the control group. During the GnRHa/chemotherapy cotreatment the concentrations of FSH, LH, and P decreased to almost prepubertal levels. However, within 1-3 months after the last GnRHa injection, an increase in LH and FSH concentrations was detected, followed several weeks later in by an increase in P concentrations to within normal levels. Conclusion(s) GnRHa administration before and during combination chemotherapy for breast cancer may preserve posttreatment ovarian function in women <40 years. Long-term studies are required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Ahmed Badawy has had multiple studies retracted, indicating issues with research integrity.”
From Using artificial intelligence to semi-automate trustworthiness assessment of randomized controlled trials: a case study (2025) · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Cancer—Principles & Practice of Oncology
Rhoads, J. E. (1983) · PubMed Central · Cited by 1,466
Sklar, C. A., Mertens, A. C., Mitby, P., Whitton, J., Stovall, M., Kasper, C., Mulder, J., Green, D., Nicholson, H. S., Yasui, Y., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj243 · Cited by 568
Letter: Serotyping of E. coli.
Rb, S. (1976) · PubMed · Cited by 391
Failure to preserve fertility in patients with Hodgkin's disease
Waxman, J. H., Ahmed, R., Smith, D., Wrigley, P. F. M., Gregory, W., Shalet, S., Crowther, D., Rees, L. H., Besser, G. M., Malpas, J. S., et al. (1987) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00254570 · Cited by 319
Blumenfeld, Z. (2007) · The Oncologist · doi:10.1634/theoncologist.12-9-1044 · Cited by 275
Blumenfeld, Z., Avivi, I., Linn, S., Epelbaum, R., Ben-Shahar, M., & Haim, N. (1996) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a019457 · Cited by 265
Fertility Preservation in Young Women Undergoing Breast Cancer Therapy
Sonmezer, M., & Oktay, K. (2006) · The Oncologist · doi:10.1634/theoncologist.11-5-422 · Cited by 261
GLODE, L. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92301-1 · Cited by 259
Recchia, F., Sica, G., Filippis, S. D., Saggio, G., Rosselli, M., & Rea, S. (2002) · Anti-Cancer Drugs · doi:10.1097/00001813-200204000-00011 · Cited by 88
Cited by
Items 301–339 of 339
Preservação da Fertilidade - estado da arte Artigo de Revisão Bibliográfica
Patrícia, V., & Henriques, P. (2015)
Ng, K., Hollis, B. W., & Fuchs, C. S. (2011)
Behoud van fertiliteit bij vrouwen na behandeling voor kanker: stand van zaken
Timperman, L. (2014)
Applegarth, L. D., Oates, R. D., & Schlegel, P. N. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9780511997761.020
Fertility preservation strategies
Kristensen, S. G., Greve, T., & Andersen, C. Y. (2012) · CRC Press eBooks · doi:10.3109/9781841849737-31
Cancer biology, epidemiology and treatment
Donnez, J., & Kim, S. S. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511921896.007
Fertility preservation in the female with cancer
Rodriguez‐Wallberg, K. A., & Oktay, K. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9780511997761.031
Options for Preserving Fertility
Goetsch, A. L., Kimelman, D., & Woodruff, T. K. (2017) · Springer eBooks · doi:10.1007/978-3-319-52316-3_1
Protective mechanisms of triptorelin against tripterygium glycoside-induced ovarian dysfunction
Zhao, Y. C., Lv, L., Li, D. S., Zhao, J., & Wang, H. Y. (2018) · Biomedical Research - India · doi:10.4066/biomedicalresearch.29-17-486
Stachs, A., Hartmann, S., & Gerber, B. (2018) · TumorDiagnostik & Therapie · doi:10.1055/a-0574-4892
de Albuquerque, F. C., Gomes, I. M., Mattos, L. A., & de Oliveira, M. S. (2017) · Human Reproduction Archives · doi:10.4322/hra.000317
Letter to the editor: Reply of the authors
Schmidt, K. T., Rosendahl, M., Ernst, E., Loft, A. G., Andersen, A. N., & Andersen, C. Y. (2011) · Research at the University of Copenhagen (University of Copenhagen)
Seli, E. U. (2011) · Wiley eBooks · doi:10.1002/9781444393958.ch17
Goldman, K. N. (2019) · Springer eBooks · doi:10.1007/978-3-030-02868-8_8
Preserving Fertility in Patients with Gastrointestinal Cancers
Tunalı, D., Oğuz, S. Y., Selek, U., Balık, E., Tonyalı, Ş., Yazıcı, S., & Öktem, Ö. (2019) · Springer eBooks · doi:10.1007/978-3-030-18890-0_35
Role of GnRH Agonists for Fertility Preservation in Breast Cancer
Villarreal-Garza, C. M., Lopez-Martinez, E. A., & Azim, H. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-24086-8_11
Gonadale Toxizität und Infertilität durch antineoplastische Substanzen
Amsberg, G. V., & Bokemeyer, C. (2020) · Springer Reference Medizin · doi:10.1007/978-3-662-46764-0_285-1
Use of GnRH Analogs for Prevention of Chemotherapy-Induced Gonadotoxicity
Lambertini, M., Horicks, F., & Demeestere, I. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108784368.016
Volochayeva, M. V., Шмаков, Р. Г., & Демина, Е. А. (2014) · Clinical oncohematology · doi:10.21320/2500-2139-2014-7-2-114-121
Hormonal Suppression for Ovarian Protection
Blondeaux, E., Spinaci, S., & Lambertini, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-47767-7_7
Current awareness: Pharmacoepidemiology and drug safety
John Wiley & Sons, L. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1652
Jadoul, P., Dolmans, M., & Donnez, J. (2012) · Springer eBooks · doi:10.1007/978-1-4419-9848-4_14
Bedaiwy, M. A., Hurd, W. W., Abou-Setta, A. M., Desai, N., & Falcone, T. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.07.1113
Risk of Transplanting Cryopreserved Ovarian Tissue in Women with Malignancies
Domingo, J., Sánchez-Serrano, M., & Pellicer, A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5617-9_12
Preservation of Ovarian Function During Chemotherapy
(2010) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000390400.78204.54
Fertility preservation medicine: A new field in the care of young cancer survivors—response
Oktay, K., Sönmezer, M., & Öktem, Ö. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22154
Gonadal Dysfunction and Fertility Preservation in Hodgkin Lymphoma Patients
Behringer, K., von Wolff, M., & Mead, G. M. (2010) · Springer eBooks · doi:10.1007/978-3-642-12780-9_24
Adolescents and Young Adults (AYA)
Onkologie, Ö. G. F. H. &. M., Borchmann, P., & Onkologie, D. G. F. H. U. M. (2016) · PUBLISSO (German National Library of Medicine) · doi:10.4126/frl01-006400997
Fertilitätsprotektion bei onkologischen und nichtonkologischen Erkrankungen
von Wolff, M., & Nawroth, F. (2026) · Gynäkologische Endokrinologie · doi:10.1007/s10304-025-00666-6
Mise au point et validation de protocoles de cryoconservation du tissu ovarien humain
Sanfilippo, S. (2012) · theses.fr (ABES) · doi:10.70675/604f5eeezb907z4adfz8278z8afb0889d8b3
How Reliable Are Our Clinical Guidelines? The Impact of Retracted Trials in Oncology
Rowell, N. P. (2026) · Clinical Oncology · doi:10.1016/j.clon.2026.104328
Nawroth, F., & von Wolff, M. (2026) · Springer eBooks · doi:10.1007/978-3-032-28679-6_33
Роль антимюллерова гормона в женской репродукции
Н., К. И., & Сергеевна, Д. Ю. (n.d.) · CyberLeninK (CyberLeninka)
Torre, A. (2012) · theses.fr (ABES) · doi:10.70675/91c56c1dzf435z47bfzb3f3z5460c1dd4eda
Blumenfeld, Z. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.09.037
Rousset‐Jablonski, C., & Dagousset, I. (2012) · ONCOLOGIE · doi:10.1007/s10269-012-2176-3
Donnez, J., & Kim, S. S. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511921896.004
Metadata
- Authors
- Badawy, A., Elnashar, A., El-Ashry, M., & Shahat, M.
- Affiliations
- Mansoura University (EG)
- Benha University (EG)
- Corresponding author
- Badawy, Ahmed
- Venue
- Fertility and Sterility
- Publisher
- Elsevier BV
- Published
- 2009-03
- Volume
- 91
- Issue
- 3
- Pages
- 694-697
- ISSN
- 0015-0282 (ISSN-L)
- OpenAlex
- W2101897761
- Cited by
- 331
- References
- 15
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 2 · 2023: 5 · 2022: 5 · 2021: 9 · 2020: 5 · 2019: 14 · 2018: 12 · 2017: 18 · 2016: 14 · 2015: 21 · 2014: 23 · 2013: 31 · 2012: 50
- FWCI
- 35.35
- Type
- journal article
- Language
- en
- Status
- Retracted
- Update notices
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Fertility and Sterility (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Keywords
- GnRH agonist, chemotherapy-induced ovarian damage, breast cancer, ovarian preservation, chemotherapy-induced amenorrhea, ovarian failure, FSH and LH levels, estrogen and progesterone, young women
- MeSH terms
- Adenocarcinoma, Adult, Amenorrhea, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Drug Administration Schedule, Estradiol, Female, Fertility Agents, Female, Humans, Infertility, Female, Luteinizing Hormone, Gonadotropin-Releasing Hormone, Lymph Node Excision, Mastectomy, Menstruation, Ovary, Ovulation, Progesterone, Prospective Studies, Time Factors, Primary Ovarian Insufficiency, Treatment Outcome, Chemotherapy, Adjuvant, Goserelin, Follicle Stimulating Hormone, Human
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
